AHFS Drug Information: A Comprehensive and Evidence-Based Source of Drug Information
AHFS Drug Information (AHFS DI) is a print compendium of drug information that is written and published by pharmacists and reviewed by over 500 experts. It is the most comprehensive evidence-based source of drug information complete with therapeutic guidelines and off-label uses. It is also the only print compendium designated by the US Congress and the only reference published by a non-profit scientific association, the American Society of Health-System Pharmacists (ASHP).[^1^]
AHFS DI covers more than 1,200 drug monographs arranged by AHFS pharmacologic-therapeutic classification. Each monograph includes information on chemistry and stability, pharmacology, pharmacokinetics, uses, cautions, toxicity, drug interactions, laboratory test interferences, dosage and administration (including dosage in renal impairment), and preparations.[^2^]
AHFS DI is updated annually and is available in print and electronic formats. It is also integrated with other ASHP resources such as AHFS Clinical Drug Information, AHFS DI Essentials, AHFS Patient Medication Information, AHFS Medication Guides, AHFS Pharmacologic-Therapeutic Classification, and ASHP Drug Shortages Center.[^3^]
AHFS DI is a valuable resource for pharmacists, physicians, nurses, and other health care professionals who need reliable and unbiased information on drugs and their use in various clinical settings. It is also useful for students, researchers, and policy makers who want to learn more about the evidence base for drug therapy.
If you are interested in accessing AHFS DI online or downloading a free PDF version of the 2013 edition, you can visit the ASHP website at https://ahfsdruginformation.com/.
However, if you are looking for a thrilling story about a sailor who escapes from his captors with the help of a mysterious drug called dicie, you might be disappointed. Dicie is not a real drug name and has nothing to do with AHFS DI. It seems that you have entered a random keyword that does not match your search intent. Please try again with a more specific and relevant keyword.
AHFS DI is based on the best available evidence from primary literature, clinical trials, and systematic reviews. It also incorporates expert opinions and consensus statements from authoritative sources such as the FDA, CDC, NIH, WHO, and professional societies. AHFS DI strives to provide objective and balanced information that reflects the current state of knowledge and practice in drug therapy.
AHFS DI is not only a source of drug information, but also a tool for improving patient care and outcomes. It supports clinical decision making by providing guidance on appropriate drug selection, dosing, monitoring, and patient education. It also helps to prevent and manage adverse drug events, drug interactions, and medication errors. AHFS DI promotes the safe and effective use of drugs in various patient populations and settings.
AHFS DI is widely recognized and respected as a standard reference in the field of pharmacy and pharmacotherapy. It has been endorsed by several organizations such as the Joint Commission, the American Medical Association, the American Academy of Pediatrics, and the American College of Physicians. It has also been cited in numerous publications and legal cases as a reliable and authoritative source of drug information. aa16f39245